Faculty introduction, disclosures

Introduction content: Review of male osteoporosis · Epidemiology Natural history of bone loss in men, defining clinical features Causes and risk factors Impact of fracture on patient outcomes Barriers to identification of osteoporosis in men, fracture risk, and whom to screen [Learning objective #1] Diagnosis and the consequences of under-diagnosis [Learning objective #1]

Treatment options · Consideration of underlying conditions and related treatment · Non-pharmacologic, nutritional, and over-the-counter recommendations and lifestyle modifications · Who should receive therapy (eu- vs. hypogonadal men, androgen-deprivation therapy, etc.) · Choice of agent, mono- vs. combination therapy [Learning objective #2] Benefits and risks of therapy: the evidence [Learning objective #2] Monitoring response, duration of therapy [Learning objective #2] Individualizing therapy and barriers to effective treatment [Learning objective #2] Investigational therapies · Patient case(s) [Learning objective #3]

Summary, conclusions, and best practice recap

By the end of the session the participant will be able to:

• Recall the challenges preventing earlier diagnosis of osteoporosis in men and the consequences of under-diagnosis
• Identify the treatment modalities currently available for management of osteoporosis in men and discuss the evidence supporting them
• Formulate a treatment plan for a male patient with osteoporosis

ACCME Activity #201759862

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

Faculty Disclosure: Peng Thim Fan, MD, FACP, Clinical Professor of Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA, has received financial compensation for Speakers’ Bureau from Amgen (Prolia, Evenity), Abbvie, Pfizer, Sanofi, Genzyme Regeneron, Radius (Tymlos).

Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.

All relevant financial relationships have been mitigated.

ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Commercial Support Disclosure: This program is supported by an educational grant from Amgen.

• Read the learning objectives above
• Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
• View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
• Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
• Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

*Required to view Printable PDF Version